The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "congestive heart failure"

Search results for: congestive heart failure

Myositis & the Heart: New Perspectives on the Pathogenesis & Management of Cardiac Involvement in Myositis

February 18, 2021 • By Carina Stanton

Experts discuss the diagnosis and treatment of myositis-related cardiovascular disease.... [Read More]

Filed Under: ACR Convergence, Conditions, Meeting Reports Tagged With: ACR Convergence 2020, cardiovascular, heart, Heart Disease, myocarditis, myositis

Study Finds NSAIDs Raise Heart Disease Risk in Osteoarthritis Patients

February 16, 2021 • By Susan Bernstein

In a controlled, large-cohort, longi­tudinal study from Canada, Atiquazzaman et al. found that use of non-steroidal anti-inflammatory drugs (NSAIDs) substantially contributes to increased cardiovascular disease risk among people with osteoarthritis (OA).1  This is the first study to evaluate the mediating role that NSAIDs play in the association between OA and cardiovascular disease (CVD), and the… [Read More]

Filed Under: Conditions, Osteoarthritis, Research Reviews Tagged With: Cardiovascular disease, Nonsteroidal anti-inflammatory drugs (NSAIDs)

Autoimmune Inflammation Increases Risk of Heart Disease

January 19, 2018 • By Susan Bernstein

SAN DIEGO—It’s no secret: Autoimmune, inflammatory rheumatic disease raises a patient’s risk of cardiovascular disease (CVD). “Inflammation may affect all aspects of the cardiac structure and function,” said Rekha Mankad, MD, FACC, director of the Women’s Heart Clinic at the Mayo Clinic in Rochester, Minn. Dr. Mankad also oversees a cardio-rheumatology clinic to assess and treat… [Read More]

Filed Under: Conditions, Meeting Reports Tagged With: ACR/ARHP Annual Meeting, autoinflammatory, Cardiovascular disease, Heart Disease, patient care

2014 ACR/ARHP Annual Meeting: Diagnosis, Management of Sarcoidosis in the Heart, Central Nervous System

March 1, 2015 • By Kathy Holliman

Without reliable diagnostic tests or evidence-based treatment guidelines, patient symptoms critical to diagnosing disease... [Read More]

Filed Under: Conditions, Meeting Reports, Systemic Inflammatory Syndromes Tagged With: ACR/ARHP Annual Meeting, central nervous system, Diagnosis, heart, Holliman, rheumatology, Sarcoidosis

The Heart-SCC Puzzle

May 1, 2009 • By Olga Kaloudi, MD, and Marco Matucci Cerinic, MD, PhD

Identifying and treating cardiac involvement in systemic sclerosis can be a challenge... [Read More]

Filed Under: Conditions, Scleroderma Tagged With: Cardiac, Diagnosis, Systemic sclerosis, Treatment

Case Report: Drug-Induced Lupus & ANCA-Associated Vasculitis Overlap

February 16, 2021 • By Mohammad A. Ursani, MD, RhMSUS, Ojas Naik, MD, Rohaan Khan & William F. Glass II, MD, PhD

Drug-induced lupus erythe­matosus and ANCA-associated vasculitis (AAV) are both autoimmune conditions associated with the use of hydralazine, a commonly prescribed drug for hypertension and congestive heart failure. Although the pathogenesis is unknown, it is believed that hydralazine alters neutrophil and lymphocyte function and promotes exposure of antigens, leading to the development of anti-neutrophil antibodies (ANCA)… [Read More]

Filed Under: Conditions, SLE (Lupus), Vasculitis Tagged With: ANCA-Associated Vasculitis, case report, hydralazine

The History of ACE Inhibitors in Scleroderma Renal Crisis

February 16, 2021 • By Ruth Jessen Hickman, MD

Lost and found

Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler… [Read More]

Filed Under: Conditions, Scleroderma Tagged With: ACE inhibitors, Lost & Found, Renal disease

ACR Introduces Draft Guideline for RA Management

November 23, 2020 • By Jason Liebowitz, MD

Treating RA can be complicated, especially if the patient is suffering from comorbidities. In a session at ACR Convergence 2020, experts discussed the development of a new ACR draft guideline for RA management & how it can be applied in real-life clinical practice.... [Read More]

Filed Under: ACR Convergence, Conditions, Guidelines, Meeting Reports, Rheumatoid Arthritis Tagged With: ACR Convergence 2020, ACR Convergence 2020 – RA

The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

March 17, 2020 • By Steven M. Harris, Esq.

In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.... [Read More]

Filed Under: Legal, Professional Topics Tagged With: COVID-19, telehealth, telemedicine

Learn to Navigate the Seas of Uncertainty in Rheumatology Training

August 16, 2019 • By Richard Zamore, MD, MPH

Rheumatology is a field rife with uncertainty. With regard to both diagnosis and treatment, we live in a world of rare diseases that are difficult to study. As a result, we are often left without an answer to our diagnostic dilemmas and without clarity when deciding the best treatment options for our patients. For rheumatologists… [Read More]

Filed Under: Career Development, Education & Training, Professional Topics Tagged With: Fellows-in-Training

  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.